4/A: TRxADE HEALTH CEO Corrects Ownership Details in Amended SEC Filing

Surendra Ajjarapu, CEO of TRxADE HEALTH, files an amended SEC Form 4 to correct previously reported information regarding securities acquired, beneficial ownership, and form of ownership.

Summary

• Surendra K. Ajjarapu, Chairman and CEO of TRxADE HEALTH, INC, filed an amended Form 4 with the SEC on May 28, 2024.
• This amendment corrects the original Form 4 filed on January 16, 2024.
• The corrections pertain to the number of securities acquired on or about January 5, 2024, the amount of securities beneficially owned as of that date, and the form of ownership.
• On January 5, 2024, Mr. Ajjarapu acquired 10,000 shares of Common Stock at $0 as consideration for services rendered.
• Following the reported transactions, Mr. Ajjarapu directly owns 82,643 shares of Common Stock.
• He is also deemed the indirect beneficial owner of 3,449 shares held by his spouse, Sandhya Ajjarapu, 34,844 shares held by the Surendra Ajjarapu Revocable Trust 2007, and 89,167 shares held by the Sandhya Ajjarapu Revocable Trust 2007.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing. The sentiment is neutral as it simply corrects previously reported information. The correction itself doesn't indicate positive or negative performance, but rather a commitment to accuracy.

Positives

• The filing provides transparency regarding the CEO's ownership stake in the company.
• The amendment corrects previous inaccuracies, ensuring accurate information is available to investors.

Industry Context

This filing is a routine part of regulatory compliance for corporate insiders and provides transparency to the market regarding their holdings in the company.

Stakeholder Impact

• Shareholders benefit from accurate reporting of insider ownership.

Key Dates